GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples